Tenax Therapeutics, Inc. is a specialty pharmaceutical company based in Morrisville, North Carolina, dedicated to developing innovative therapies aimed at treating cardiovascular and pulmonary diseases. The company is actively advancing its proprietary drug pipeline, with a strategic focus on addressing significant unmet medical needs within critical care environments across the U.S. and Canada. Through a robust commitment to research and development, Tenax is poised to deliver novel therapeutic solutions that enhance patient outcomes and capitalize on growth opportunities in vital healthcare sectors. Show more

Location: 101 GLEN LENNOX DRIVE, CHAPEL HILL, NC, UNITED STATES, 27517, Chapel Hill, NC, 27517, USA | Website: https://www.tenaxthera.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE


Market Cap

78.11M

52 Wk Range

$4.63 - $18.38

Previous Close

$12.51

Open

$12.30

Volume

247,919

Day Range

$12.24 - $13.18

Enterprise Value

408.2M

Cash

99.37M

Avg Qtr Burn

-9.155M

Insider Ownership

0.31%

Institutional Own.

-

Qtr Updated

09/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
TNX-103 (Oral Levosimendan) Details
Pulmonary hypertension in heart failure with preserved ejection fraction (PH-HFpEF)

Phase 3

Data readout